In recent years, several spacecraft failed in their attempts to land on the moon. But 2025 may offer crucial second chances.
Syantra, Inc., a precision biotechnology company revolutionizing cancer detection and treatment, proudly announces the appointment of Holly Smithson to its Board of Directors.